Active surveillance in patients with a PSA >10 ng/mL

INTRODUCTION: The use of prostate-specific antigen (PSA) in active surveillance (AS) for prostate cancer is controversial. Some consider it an unreliable marker and others as sufficient evidence to exclude patients from AS. We analyzed our cohort of AS patients with a PSA over 10 ng/mL. METHODS: We...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Toren, Paul, Wong, Lih-Ming, Timilshina, Narhari, Alibhai, Shabbir, Trachtenberg, John, Fleshner, Neil, Finelli, Antonio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Canadian Medical Association 2014
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216302/
https://ncbi.nlm.nih.gov/pubmed/25408810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2121
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg